Perrigo Sues IRS For $163M From Drug Sales, Patent Rows
Generic pharmaceutical giant Perrigo Co. PLC pushed a Michigan federal judge on Tuesday to order the Internal Revenue Service to return more than $163 million in refunds tied to its sales...To view the full article, register now.
Already a subscriber? Click here to view full article